22-19523831-ATGT-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_001363066.2(CLDN5):c.422_424delACA(p.Asn141del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001363066.2 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN5 | NM_001363066.2 | c.422_424delACA | p.Asn141del | disruptive_inframe_deletion | Exon 1 of 1 | ENST00000618236.2 | NP_001349995.1 | |
CLDN5 | NM_001130861.1 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 1 of 1 | NP_001124333.1 | ||
CLDN5 | NM_001363067.2 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 2 of 2 | NP_001349996.1 | ||
CLDN5 | NM_003277.4 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 2 of 2 | NP_003268.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN5 | ENST00000618236.2 | c.422_424delACA | p.Asn141del | disruptive_inframe_deletion | Exon 1 of 1 | 6 | NM_001363066.2 | ENSP00000480623.1 | ||
CLDN5 | ENST00000403084.1 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 1 of 1 | 6 | ENSP00000384554.1 | |||
CLDN5 | ENST00000406028.1 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 2 of 2 | 2 | ENSP00000385477.1 | |||
CLDN5 | ENST00000413119.2 | c.677_679delACA | p.Asn226del | disruptive_inframe_deletion | Exon 2 of 2 | 2 | ENSP00000400612.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Syndromic disease Uncertain:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3A. Following criteria are met: 0101 - Gain of function is a suggested mechanism of disease in this gene and is associated with CLDN5-related syndromic disease (MONDO:0002254). Over-expression of patient CLDN5 missense variants in a zebrafish model disrupts embryogenesis and impairs tight junction formation (PMID: 36477332). Additionally, transfected cell lines with the c.178G>A variant showed higher chloride ion permeability and lower sodium ion permeability when compared to wildtype, indicating anion-selective permeability (PMID: 35714222). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0216 - In-frame deletion in a non-repetitive region that has moderate conservation. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0600 - Variant is located in the annotated PMP22_Claudin domain (DECIPHER). (I) 0705 - No comparable in-frame variants have previous evidence for pathogenicity. (I) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.